Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT07658703

Physiotherapeutic Approach to Superficial and Deep Dyspareunia in Women With Chronic Pelvic Pain: Comparison Between In-person and Telehealth Care.

Conditions: Surface and Deep Dyspareunia

Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 72
Sponsor: University of Sao Paulo

Location: Ribeirão Preto Clinical Hospital Ribeirão Preto São Paulo

Summary

Adequate sexual function is considered an important factor in satisfaction and overall quality of life for both men and women. It is estimated 16% to 40% of women suffer from some form of sexual dysfunction, which is currently considered a public health problem and its investigation is recommended because it causes significant changes in the quality of life of these women. Among the painful disorders, genitopelvic pain, which includes dyspareunia, vaginismus and vulvodynia, dyspareunia stands out, which involves the appearance of pain during or after sexual intercourse, directly affecting physical health, as well as sexual and mental well-being. Among the treatment techniques for dyspareunia in women with chronic pelvic pain, there is the Thiele massage, which provides an inhibitory effect on muscle tension caused by spasms, relaxing, stretching and relieving coital pain. In this sense, we know that physiotherapy treatment has an important role in improving pain symptoms, since musculoskeletal dysfunction may be present in women with dyspareunia, which makes it relevant to verify whether the approach via telecare would have the same effectiveness as the in-person technique that has scientific proof, since through telecare the woman would not be exposed to the risks that are inherent to going to an outpatient clinic, it could cover more women and this would also bring a greater cost-benefit to the unified health system.

Eligibility Criteria

Inclusion Criteria: * Women diagnosed with CPP and deep or shallow penetration dyspareunia; * Over 18 years of age; * Willingness to voluntarily participate in the study, accepting randomization to either of the two treatment arms; * Signature of the Free and Informed Consent Form (FICF). Exclusion Criteria: * Women with penetrative dyspareunia without pelvic floor muscle spasm; * Women without an active sex life

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07658703). StuddyBuddy aggregates publicly available trial information.